期刊文献+

应用背向散射技术评价乳腺癌患者表阿霉素心脏毒性的价值 被引量:2

Study on the Eprirubincin-induced cardiotoxity in breast cancer patients by integrated backscatterand
下载PDF
导出
摘要 目的探讨超声背向散射(IBS)技术评价乳腺癌术后患者表阿霉素心脏毒性的价值。方法133例乳腺癌患者分为3组:A组45例,给予表阿霉素总剂量180-240mg/m^2。B组48例,给予表阿霉素总剂量≥360mg/m^2。C组为对照组,40例,未给予化疗。取胸骨旁左室长轴切面,测量A、B两组化疗前后及C组左室后壁心内膜下及心外膜下、室间隔右室侧1/2及左室侧1/2心肌的平均背向散射积分(IBS)、随心动周期变化的背向散射积分幅度(CVIB),计算各层校正背向散射积分(IBS%)以及CVIB的跨壁梯度(TGCV)、CVIB的跨壁梯度指数(TGI)。结果A组与C组、A组化疗前之间常规超声参数(LVDd、LVDs、IVSTd、LVEF、FS、E/A)及CVIB、IBS%、TGCV、TGI无显著性差异(P〉0.05)。A组与B组间常规超声参数无显著性差异(P〉0.05),B组与C组及B两组化疗前之间常规超声参数(E/A除外)无显著性差异(P〉0.05)。B组参数E/A、CVIB、TGCV、TGI显著减低、IBS%显著升高,与A组、C组及B组化疗前之间有显著性差异(P〈0.05或P〈0.01)。结论超声背向散射技术可作为早期评价乳腺癌术后患者表阿霉素心脏毒性的手段之一。 Objective To investige the Eprirubincin-induced cardiotoxity in breast cancer patients by integrated backscatter. Methods One hundred and thirty-three breast cancer patients were divided into three groups: 45 patients in group A were given Epirubicin(Epi)of 180-240 mg/m^2 , 48 patients in group B were given Epirubicin of ≥360 mg/m^2 , and 40 patients after surging without chemotherapy in group C as the control group. The integrated backscatter (IBS), cyclic variation of integrated backscatter(CVIB)were examined IBS%, then TGCV(transmural gradient of CVIB), TGI(transmural gradient index of CVIB)were obtainedand. Results The conventional echographic parameters (such as LVDd, LVDs, IVSTd, LVEF, FS, E/A ) and CVIB, IBS%, TGCV, TGI were no significantce difference between group A and group C, so is it with A group before chemotherapy (P〉0. 05). The conventional echographic parameters were no significant difference between groups A and B (P〉0. 05). The conventional echographic parameters (E/A was not include) were no significant difference between group B and group C,so is it with group B before chemotherapy (P〉0.05). The E/A and CVIB,TGCV, TGI were considerably lower, the IBS% was considerably higher in group B. They were significant difference between groups A and B, groups C and B, group A and group C,so is it with group B before chemotherapy (P〈0.01 or P〈0.05). Conclusion IBS may be valuable to assess the Eprirubincin-induced cardiotoxity in breast cancer patients.
出处 《中国医学影像技术》 CSCD 北大核心 2007年第1期85-87,共3页 Chinese Journal of Medical Imaging Technology
关键词 背向散射积分 表阿霉素 心脏毒性 超声心动描记术 Integrated backscatter Epirubicin Cardiotoxity Echocardiagraphy
  • 相关文献

参考文献6

  • 1Adams MJ,Lipshultz SE.Pathophysiology of anthracycline and radiation-associated cardiomyopathies:implications for screening and prevention[J].Pediatr Blood Cancer,2005,44(7):600-606.
  • 2朱永胜.超声心肌组织定征的研究进展[J].中国医学影像技术,1999,15(3):231-233. 被引量:12
  • 3姜志荣,吕慧霞,张华,刘培京,何信佳.心肌背向散射积分参数评价蒽环类抗肿瘤药心脏毒性的临床研究[J].中国超声医学杂志,2004,20(1):34-37. 被引量:10
  • 4Mimbs JW,O'Donnell M,Miller JG,et al.Detection of cardiomyopathic changes induced by doxorubin based on quantitative analysis of ultrasonic backscatter[J].Am J Cardiol,1981,47(5):1056-1060.
  • 5Goens MB,Karr SS,Seibel N,et al.Ultrasound myocardial tissue characterization by integrated backscatter in children treated with anthracyclines[J].Pediatr Cardiol,1999,20(4):264-270.
  • 6Oberholzer K,Kunz RP,Dittrich M,et al.Anthracycline-induced Cardiotoxicity:Cardiac MRI after treatment for childhood cancer[J].Rofo,2004,176(9):1245-1250.

二级参考文献11

  • 1[1]Schecter SO,Teichholz LF,Klig V,et al.Ultrsonic tissue chara-cterization:Review of noninvasive technique for assessing myocardial viability.Echocardiography,1996,13:415-430
  • 2[2]Mimbs JW,O'Donnell M,Miller JG,et al.Detection of cardio-myopathic changes induced by doxorubin based on quantitative analysis of ultrasonic backscatter.Am J Cardiol,1981,47:1056-1060
  • 3[3]Zuber M,Gerber K,Erne P,et al.Myocardial tissue character-ization in heart failure by real-time integrated backscatter.Eur J Ultra,1999,9:135-143
  • 4[4]Iarussi D,Galderisi M,Ratti G,et al.Left ventricular systolic and diastolic function after anthracycline chemotherapy in childhood.Clin Cardiol,2001,24:663-669
  • 5[5]Shan K,Lincoff AM,Young JB.Anthracycline-induced cardioto-xicity.Ann Intern Med,1996,125:47-58
  • 6[6]Bu'lock FA,Mott MG,Oakhill A,et al.Left ventricular diastolic filling patterns associated with progressive anthracycline-induced myocardial damage:a prospective study.Pediatr Cardiol,1999,20:252-263
  • 7[7]Billingham M,Mason JW,Bristow MR,et al.Anthracycline cardio-myopathy monitored by morphologic changes.Cancer Treat Rep,1978,62:865-872
  • 8[8]Goens MB,Karr SS,Seibel N,et al.Ultrasound myocardial tissue characterization by integrated backscatter in children treated with anthracyclines.Pediatr Cardiol,1999,20:264-270
  • 9[9]Tjeerdsma GT,Meinardi MT,Graaf WTA,et al.Early detection of anthracycline-induced cardiotoxicity in asymptomatic patients with normal left ventricular systolic function:autonomic versus echocardiographic variables.Heart,1999,81:419-423
  • 10[10]Bu'lock FA,Mott MG,Oaakhill Aa,et al.Left ventricular diastolic function after anthracycline chemotherapy in childhood:relation with systolic function,symptoms and pathophysiology.Br Heart J,1995,73:34

共引文献20

同被引文献33

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部